PLK1 and lung carcinoma: Compared with the Lip/pDNA binary complex, the CASF/Lip/pDNA ternary complex-formed CRISPR–Cas9 gene knockout system could more effectively knock out the PLK1 gene and inhibit the proliferation of lung cancer cells.